|
Symbol
|
IHTEFG | HZJEFG | RMBFAV | Z09YGZ | PBURCH | RMA3QV | RMBRKV | ERORCH | ABMUTQ | PJIRCH | PRZRCH | Z0ARNZ | CQWBKB | RMAKRV | RMAG0V | PWCRCH | RMAKOV | LYXRCH | LYZRCH | LZJRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Reverse Convertible | Multi Vonti | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Autocallable Multi Vonti | Autocallable Multi Vonti | Autocallable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche PS / Sika AG | Kühne & Nagel Intl. AG / Lonza Group N / Sika AG | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | ABB N / Companie Financière Richemont SA / Lonza Group N | Logitech International SA / Lonza Group N / Partners Group Hldg. AG / Sika AG | Lonza Group N / SGS S.A. Ltd. / Swisscom N | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
28.06.2029 | 02.11.2026 | 13.07.2026 | 27.08.2027 | 21.07.2026 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 20.12.2029 | 16.06.2026 | 24.02.2027 | 25.08.2026 | 13.03.2028 | 24.06.2026 | 24.06.2026 | 27.06.2029 | 27.05.2026 | 07.10.2026 | 14.07.2027 | 24.07.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
176,28 | 182,298 | 208,20 | 179,883 | 57,988 | 56,14 | 197,80 | 141,44 | 6,7665 | 250,58 | 416,78 | 463,386 | 78,705 | 183,40 | 174,30 | 364,13 | 442,10 | 172,88 | 361,14 | 427,50 |
| rendement max. p.a. | - | - | 213,57% | 24,54% | - | 15,22% | 69,73% | 5,70% | 12,44% | - | 8,31% | 15,38% | 9,74% | 183,59% | 142,57% | 7,93% | 20,71% | 51,14% | 4,18% | 16,52% |
| Demande | 88,21 | 78,50 | 69,30 | - | 96,13 | 95,00 | - | 99,56 | 79,18 | 98,57 | 96,36 | - | 92,04 | 77,60 | 81,80 | 90,26 | 98,00 | 84,10 | 98,31 | 96,91 |
| Offre | - | - | 70,30 | - | - | 96,00 | - | 100,36 | 79,98 | - | 97,16 | - | 92,84 | 78,90 | 83,10 | 91,06 | 99,00 | 84,90 | 99,11 | 97,71 |